In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci

Enterococci that are nonsusceptible (NS; MIC > 4 μg/ml) to daptomycin are an emerging clinical concern. The synergistic combination of daptomycin plus beta-lactams has been shown to be effective against vancomycin-resistant Enterococcus (VRE) species in vitro. This study systematically evaluated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Hindler, Janet A., Wong-Beringer, Annie, Charlton, Carmen L., Miller, Shelley A., Kelesidis, Theodoros, Carvalho, Marissa, Sakoulas, George, Nonejuie, Poochit, Pogliano, Joseph, Nizet, Victor, Humphries, Romney
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2015
Teme:
Susceptibility
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468720/
https://ncbi.nlm.nih.gov/pubmed/25963982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05077-14
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items